首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   236176篇
  免费   11695篇
  国内免费   406篇
耳鼻咽喉   3100篇
儿科学   7349篇
妇产科学   4786篇
基础医学   33909篇
口腔科学   5718篇
临床医学   18614篇
内科学   52147篇
皮肤病学   6319篇
神经病学   21071篇
特种医学   7182篇
外国民族医学   102篇
外科学   29277篇
综合类   1019篇
一般理论   66篇
预防医学   21531篇
眼科学   4610篇
药学   16654篇
中国医学   731篇
肿瘤学   14092篇
  2023年   1261篇
  2022年   926篇
  2021年   3548篇
  2020年   2106篇
  2019年   3946篇
  2018年   7516篇
  2017年   4926篇
  2016年   4941篇
  2015年   5543篇
  2014年   5782篇
  2013年   9338篇
  2012年   16189篇
  2011年   16161篇
  2010年   8076篇
  2009年   6055篇
  2008年   13911篇
  2007年   14869篇
  2006年   13651篇
  2005年   13501篇
  2004年   12646篇
  2003年   11533篇
  2002年   10926篇
  2001年   6141篇
  2000年   6239篇
  1999年   5556篇
  1998年   946篇
  1997年   801篇
  1996年   758篇
  1992年   3209篇
  1991年   2881篇
  1990年   2755篇
  1989年   2513篇
  1988年   2391篇
  1987年   2222篇
  1986年   2111篇
  1985年   1896篇
  1984年   1404篇
  1983年   1197篇
  1982年   687篇
  1979年   1207篇
  1978年   849篇
  1977年   801篇
  1975年   802篇
  1974年   985篇
  1973年   995篇
  1972年   937篇
  1971年   923篇
  1970年   861篇
  1969年   906篇
  1968年   793篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
72.
73.
74.
75.
76.
77.

Introduction

The fast track / ultra-fast-track protocols are techniques used to optimise the patient care process and a quick recovery after cardiac surgery. They are one of the mainstays of efficient practice. With their use, the length of hospital and intensive care unit (ICU) stays are reduced, with a direct impact on costs and the quality of the health service.

Objective

To compare the length of stay in the ICU, length of hospital stay, and post-operative mortality in ultra-fast-track extubated (uFTE) patients and those with conventional extubation (CE) after cardiac surgery.

Methods

Longitudinal, analytical, retrospective study was conducted, with the period between the time of surgery and discharge being included as the study period.

Results

A total of 396 patients older than 18 years who required cardiac surgery were included, of whom 207 patients had (uFTE) and 189 had CE. Although the groups were not comparable due to the statistical differences found, when performing the multivariate adjustment, uFTE maintained its statistical independence and was associated with lower cardiovascular morbidity, such as myocardial ischaemia (95% CI: 0.37-0.86; P = .01) and lower post-surgical vasopressor requirement (95% CI: 0.18-0.49; P < .01). No significant differences were found in the length of hospital stay, ICU stay, or post-operative mortality in the ICU.

Conclusion

Implementing the uFTE strategy, decreases cardiovascular morbidity and vasopressor requirement. The change to uFTE should be accompanied by changes in models and practices in patient recovery to standardised protocols. This study shows that uFTE did not reduce the length of ICU stay, hospital stay, or mortality.  相似文献   
78.
79.
80.
Introduction: The rising prevalence of musculoskeletal pathologies in developed countries has caused a dramatic impact on social welfare. Amidst these musculoskeletal pathologies is Rheumatoid arthritis (RA), a chronic systemic autoimmune disease that mostly affects the synovium. RA metabolic-associated alterations, including distorted adipokine production, enhance RA inflammatory environment. Among the altered adipokines, visfatin is particularly involved in RA inflammation and catabolism and stands out as an essential enzyme linked to critical cell features.

Areas covered: We discuss the potential mechanism supporting the contribution of visfatin to RA and the association between RA and obesity. We discuss the repurposing of cancer-tested drugs to inhibit visfatin in the context of RA. Additionally, we address the possibility of combining these drugs with current RA therapy. Finally, we explore the future of visfatin as an RA biomarker or therapeutic target.

Expert opinion: Inhibition of visfatin has become an interesting therapeutic approach for RA pathology. Such a feat has already been attained in oncology using small molecule inhibitors, which suggest that a similar course of action would be worth pursuing in the RA context. Visfatin will become an important biomarker and therapeutic target for RA.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号